药理临床研究
Search documents
寿仙谷:公司正在开展去壁灵芝孢子粉与抗肿瘤药物联用的研究
Zheng Quan Ri Bao Wang· 2025-09-26 11:41
Core Viewpoint - The company emphasizes its commitment to innovation and product efficacy enhancement across the entire industry chain, focusing on traditional and modern practices in its operations [1] Group 1: Product Innovation - The company has developed a unique wall-breaking technology that removes the shell of Ganoderma lucidum spore powder, resulting in over tenfold increases in the content of effective components [1] - The absorption rates of different effective components have improved by 4 to 50 times due to this new technology [1] Group 2: Research and Development - The company is conducting research on the combination of wall-broken Ganoderma lucidum spore powder with anti-tumor drugs, with some results already published in academic papers [1]